- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.30 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x YB: YTTERBIUM (III) ION(Non-covalent)
YB.1: 4 residues within 4Å:- Chain A: D.200, D.202, H.286
- Ligands: EMA.2
5 PLIP interactions:5 interactions with chain A- Metal complexes: A:D.200, A:D.200, A:D.202, A:D.202, A:H.286
YB.3: 4 residues within 4Å:- Chain B: D.200, D.202, H.286
- Ligands: EMA.4
3 PLIP interactions:3 interactions with chain B- Metal complexes: B:D.200, B:D.202, B:H.286
YB.5: 4 residues within 4Å:- Chain C: D.200, D.202, H.286
- Ligands: EMA.6
4 PLIP interactions:4 interactions with chain C- Metal complexes: C:D.200, C:D.200, C:D.202, C:H.286
- 3 x EMA: (ADENIN-9-YL-ETHOXYMETHYL)-HYDROXYPHOSPHINYL-DIPHOSPHATE(Non-covalent)
EMA.2: 17 residues within 4Å:- Chain A: R.38, K.55, L.57, V.59, K.62, S.63, K.81, A.199, D.202, G.256, T.257, H.286, G.287, T.288, E.289, N.292
- Ligands: YB.1
13 PLIP interactions:13 interactions with chain A- Hydrogen bonds: A:S.63, A:S.63, A:S.63, A:T.257, A:T.288
- Water bridges: A:D.200, A:D.200
- Salt bridges: A:R.38, A:K.55, A:K.55, A:K.81, A:K.81
- pi-Cation interactions: A:H.286
EMA.4: 17 residues within 4Å:- Chain B: R.38, K.55, L.57, V.59, K.62, S.63, K.81, A.199, D.202, G.256, T.257, H.286, G.287, T.288, E.289, N.292
- Ligands: YB.3
14 PLIP interactions:14 interactions with chain B- Hydrogen bonds: B:K.55, B:S.63, B:S.63, B:S.63, B:T.257, B:H.286, B:G.287
- Water bridges: B:D.200
- Salt bridges: B:R.38, B:K.55, B:K.55, B:K.81, B:K.81
- pi-Stacking: B:H.286
EMA.6: 16 residues within 4Å:- Chain C: R.38, K.55, G.61, K.62, S.63, K.81, A.199, D.202, T.257, H.286, G.287, T.288, E.289, D.291, N.292
- Ligands: YB.5
14 PLIP interactions:14 interactions with chain C- Hydrogen bonds: C:K.55, C:S.63, C:S.63, C:S.63, C:T.257, C:T.257
- Water bridges: C:D.200, C:D.200
- Salt bridges: C:R.38, C:K.55, C:K.55, C:K.81, C:K.81
- pi-Cation interactions: C:H.286
- 6 x CA: CALCIUM ION(Non-covalent)
CA.7: 5 residues within 4Å:- Chain D: D.129, D.131, D.133, Q.135, E.140
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.131, D:D.131, D:D.133, D:Q.135, D:E.140
CA.8: 5 residues within 4Å:- Chain D: D.93, D.95, N.97, Y.99, E.104
5 PLIP interactions:5 interactions with chain D- Metal complexes: D:D.93, D:D.95, D:Y.99, D:E.104, D:E.104
CA.9: 7 residues within 4Å:- Chain E: D.129, D.131, D.133, Q.135, V.136, N.137, E.140
5 PLIP interactions:5 interactions with chain E- Metal complexes: E:D.131, E:D.131, E:D.133, E:Q.135, E:E.140
CA.10: 5 residues within 4Å:- Chain E: D.93, D.95, N.97, Y.99, E.104
5 PLIP interactions:5 interactions with chain E- Metal complexes: E:D.93, E:D.95, E:Y.99, E:E.104, E:E.104
CA.11: 5 residues within 4Å:- Chain F: D.129, D.131, D.133, Q.135, E.140
5 PLIP interactions:5 interactions with chain F- Metal complexes: F:D.131, F:D.133, F:Q.135, F:E.140, F:E.140
CA.12: 5 residues within 4Å:- Chain F: D.93, D.95, N.97, Y.99, E.104
4 PLIP interactions:4 interactions with chain F- Metal complexes: F:D.93, F:D.95, F:Y.99, F:E.104
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shen, Y. et al., Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc.Natl.Acad.Sci.USA (2004)
- Release Date
- 2004-02-10
- Peptides
- Calmodulin-sensitive adenylate cyclase: ABC
Calmodulin: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.30 Å
- Oligo State
- hetero-3-3-mer
- Ligands
- 3 x YB: YTTERBIUM (III) ION(Non-covalent)
- 3 x EMA: (ADENIN-9-YL-ETHOXYMETHYL)-HYDROXYPHOSPHINYL-DIPHOSPHATE(Non-covalent)
- 6 x CA: CALCIUM ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Shen, Y. et al., Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc.Natl.Acad.Sci.USA (2004)
- Release Date
- 2004-02-10
- Peptides
- Calmodulin-sensitive adenylate cyclase: ABC
Calmodulin: DEF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F